Rayten Michal Ety Mitrany - 25 May 2026 Form 4 Insider Report for Brainsway Ltd. (BWAY)

Reporting relationship: Director
Issuer ticker: BWAY
Reported as of: 25 May 2026
Net transaction value: $0
SEC form: 4
Accepted by SEC: 26 May 2026, 16:02:54 UTC
Prior SEC filing: 21 May 2026
Source filing: View source filing
Reporting owner signature: /s/ Ety Mitrany

Key filing fact

Rayten Michal Ety Mitrany filed Form 4 for Brainsway Ltd. (BWAY) on 26 May 2026.

Key facts

This page summarizes Rayten Michal Ety Mitrany's Form 4 filing for Brainsway Ltd. (BWAY).
2 reported transactions and 0 derivative rows are listed below.
Accepted by SEC: 26 May 2026, 16:02.

Change

Previous filing in this sequence was filed on 21 May 2026.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0002111631 Primary reporting owner

Mitrany Rayten Michal Ety

Relationship: Director
Address: 16 HARTUM STREET, RAD TOWER, 14TH FLOOR, HAR HAHOTZVIM, JERUSALEM, ISRAEL
Signature: /s/ Ety Mitrany
Signature date: 26 May 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

BWAY transaction

Ordinary Shares

Sale

Transaction value
Shares: -10,000
Change %: -33%
Price
Shares after: 20,480
Date: 25 May 2026
Ownership: Direct
Footnotes: F1, F2, F3

BWAY transaction

Ordinary Shares

Sale

Transaction value
Shares: -7,980
Change %: -39%
Price
Shares after: 12,500
Date: 26 May 2026
Ownership: Direct
Footnotes: F1, F3, F4

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 4 footnotes

Footnote F1

The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.

Footnote F2

The sale price was NIS 45.5588 per share.

Footnote F3

This figure includes ordinary shares and unvested restricted stock units ("RSUs") to receive 6,250 ordinary shares that vest quarterly until March 5, 2028, with each RSU representing a contingent right to receive one ordinary share.

Footnote F4

The sale price was NIS 44.7516 per share.